Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Dose addition of intravenous metronidazole to oral vancomycin improve outcomes in Clostridioides difficile infection?

Wang Y, Schluger A, Li J, Gomez-Simmonds A, Salmasian H, Freedberg D.

Clin Infect Dis. 2019 Nov 12. pii: ciz1115. doi: 10.1093/cid/ciz1115. [Epub ahead of print]

PMID:
31714955
2.

Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation.

Annavajhala MK, Gomez-Simmonds A, Macesic N, Sullivan SB, Kress A, Khan SD, Giddins MJ, Stump S, Kim GI, Narain R, Verna EC, Uhlemann AC.

Nat Commun. 2019 Oct 17;10(1):4715. doi: 10.1038/s41467-019-12633-4.

3.

Emergence of Polymyxin Resistance in Clinical Klebsiella pneumoniae Through Diverse Genetic Adaptations: A Genomic, Retrospective Cohort Study.

Macesic N, Nelson B, Mcconville TH, Giddins MJ, Green DA, Stump S, Gomez-Simmonds A, Annavajhala MK, Uhlemann AC.

Clin Infect Dis. 2019 Sep 12. pii: ciz623. doi: 10.1093/cid/ciz623. [Epub ahead of print]

PMID:
31513705
4.

Escherichia coli Harboring mcr-1 in a Cluster of Liver Transplant Recipients: Detection through Active Surveillance and Whole-Genome Sequencing.

Macesic N, Khan S, Giddins MJ, Freedberg DE, Whittier S, Green DA, Furuya EY, Verna EC, Annavajhala MK, Gomez-Simmonds A, Uhlemann AC.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02680-18. doi: 10.1128/AAC.02680-18. Print 2019 Jun.

5.

Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat.

Annavajhala MK, Gomez-Simmonds A, Uhlemann AC.

Front Microbiol. 2019 Jan 31;10:44. doi: 10.3389/fmicb.2019.00044. eCollection 2019.

6.

Clonal Background, Resistance Gene Profile, and Porin Gene Mutations Modulate In Vitro Susceptibility to Imipenem-Relebactam in Diverse Enterobacteriaceae.

Gomez-Simmonds A, Stump S, Giddins MJ, Annavajhala MK, Uhlemann AC.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00573-18. doi: 10.1128/AAC.00573-18. Print 2018 Aug.

7.

Genomic and Geographic Context for the Evolution of High-Risk Carbapenem-Resistant Enterobacter cloacae Complex Clones ST171 and ST78.

Gomez-Simmonds A, Annavajhala MK, Wang Z, Macesic N, Hu Y, Giddins MJ, O'Malley A, Toussaint NC, Whittier S, Torres VJ, Uhlemann AC.

MBio. 2018 May 29;9(3). pii: e00542-18. doi: 10.1128/mBio.00542-18.

8.

Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients.

Macesic N, Gomez-Simmonds A, Sullivan SB, Giddins MJ, Ferguson SA, Korakavi G, Leeds D, Park S, Shim K, Sowash MG, Hofbauer M, Finkel R, Hu Y, West J, Toussaint NC, Greendyke WG, Miko BA, Pereira MR, Whittier S, Verna EC, Uhlemann AC.

Clin Infect Dis. 2018 Aug 31;67(6):905-912. doi: 10.1093/cid/ciy199.

9.

Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates.

Giddins MJ, Macesic N, Annavajhala MK, Stump S, Khan S, McConville TH, Mehta M, Gomez-Simmonds A, Uhlemann AC.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02101-17. doi: 10.1128/AAC.02101-17. Print 2018 Mar.

10.

Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.

McConville TH, Sullivan SB, Gomez-Simmonds A, Whittier S, Uhlemann AC.

PLoS One. 2017 Oct 12;12(10):e0186195. doi: 10.1371/journal.pone.0186195. eCollection 2017.

11.

Reply to Aitken et al., "Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?"

Cheng L, Nelson BC, Mehta M, Shi Q, Gomez-Simmonds A, Uhlemann AC.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01163-17. doi: 10.1128/AAC.01163-17. Print 2017 Sep. No abstract available.

12.

Detection of mcr-1-Carrying Escherichia coli Causing Bloodstream Infection in a New York City Hospital: Avian Origins, Human Concerns?

Macesic N, Green D, Wang Z, Sullivan SB, Shim K, Park S, Whittier S, Furuya EY, Gomez-Simmonds A, Uhlemann AC.

Open Forum Infect Dis. 2017 May 20;4(3):ofx115. doi: 10.1093/ofid/ofx115. eCollection 2017 Summer.

13.

Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.

Gomez-Simmonds A, Uhlemann AC.

J Infect Dis. 2017 Feb 15;215(suppl_1):S18-S27. doi: 10.1093/infdis/jiw378. Review.

14.

Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC β-Lactamase-Producing Enterobacteriaceae.

Cheng L, Nelson BC, Mehta M, Seval N, Park S, Giddins MJ, Shi Q, Whittier S, Gomez-Simmonds A, Uhlemann AC.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00276-17. doi: 10.1128/AAC.00276-17. Print 2017 Jun.

15.

Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.

Satlin MJ, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG, Hamula CL, Uhlemann AC, Levi MH, Fries BC, Tang YW, Juretschko S, Rojtman AD, Hong T, Mathema B, Jacobs MR, Walsh TJ, Bonomo RA, Kreiswirth BN.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02349-16. doi: 10.1128/AAC.02349-16. Print 2017 Apr.

16.

Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistant Enterobacter cloacae and dominance of ST171, 2007-14.

Gomez-Simmonds A, Hu Y, Sullivan SB, Wang Z, Whittier S, Uhlemann AC.

J Antimicrob Chemother. 2016 Aug;71(8):2351-3. doi: 10.1093/jac/dkw132. Epub 2016 Apr 26. Review. No abstract available.

17.

Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.

Gomez-Simmonds A, Nelson B, Eiras DP, Loo A, Jenkins SG, Whittier S, Calfee DP, Satlin MJ, Kubin CJ, Furuya EY.

Antimicrob Agents Chemother. 2016 May 23;60(6):3601-7. doi: 10.1128/AAC.03007-15. Print 2016 Jun.

18.

Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant Gram-negative rods.

Nelson BC, Eiras DP, Gomez-Simmonds A, Loo AS, Satlin MJ, Jenkins SG, Whittier S, Calfee DP, Furuya EY, Kubin CJ.

Antimicrob Agents Chemother. 2015 Nov;59(11):7000-6. doi: 10.1128/AAC.00844-15. Epub 2015 Aug 31.

19.

Population Structure of Klebsiella pneumoniae Causing Bloodstream Infections at a New York City Tertiary Care Hospital: Diversification of Multidrug-Resistant Isolates.

Gomez-Simmonds A, Greenman M, Sullivan SB, Tanner JP, Sowash MG, Whittier S, Uhlemann AC.

J Clin Microbiol. 2015 Jul;53(7):2060-7. doi: 10.1128/JCM.03455-14. Epub 2015 Apr 15.

20.

Comparison of 3 severity criteria for Clostridium difficile infection.

Gomez-Simmonds A, Kubin CJ, Furuya EY.

Infect Control Hosp Epidemiol. 2014 Feb;35(2):196-9. doi: 10.1086/674851. Epub 2013 Dec 23.

Supplemental Content

Loading ...
Support Center